Virginia Retirement Systems’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.82M	Buy	233,354 +120,350	+107%	+$870K	0.01%	443
2025 Q3	$858K	Buy	113,004 +29,300	+35%	+$244K	0.01%	637
2025 Q2	$750K	Buy	83,704 +27,000	+48%	+$251K	0.01%	652
2025 Q1	$425K	Buy	+56,704	New	+$457K	﹤0.01%	798
2023 Q3	$333K	Sell	47,100 -33,500	-42%	-$241K	﹤0.01%	789
2023 Q2	$567K	Buy	80,600 +64,900	+413%	+$521K	0.01%	695
2023 Q1	$131K	Buy	15,700 +4,500	+40%	+$43.3K	﹤0.01%	990
2022 Q4	$129K	Buy	+11,200	New	+$140K	﹤0.01%	1083
2021 Q1	–	Sell	-10,500	Closed	-$78K	–	1105
2020 Q4	$78K	Hold	10,500	–	–	﹤0.01%	1090
2020 Q3	$36K	Sell	10,500 -4,400	-30%	-$18.9K	﹤0.01%	1071
2020 Q2	$71K	Buy	+14,900	New	+$59.5K	﹤0.01%	1071
2020 Q1	–	Sell	-16,900	Closed	-$58K	–	1091
2019 Q4	$58K	Buy	+16,900	New	+$42.5K	﹤0.01%	1118